You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

43 search results for: asthma

Type 2 Inflammation Mediates Severe <b>Asthma</b> in Pediatric Patients

expert video

Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients

19 min

Pulmonology

Dr. Leonard Bacharier discusses how type 2 inflammation underlies the pathophysiology of pediatric severe asthma and contributes to burden.

Burdens Experienced by Pediatric <b>Asthma</b> Patients and Their Caregivers

expert video

Burdens Experienced by Pediatric Asthma Patients and Their Caregivers

3 min

Pulmonology

Drs. Michael Blaiss and Bob Geng discuss the burdens experienced by pediatric severe asthma patients and their caregivers.

Expert Insights: Importance of Lung Function Assessment in Pediatric <b>Asthma</b> Patients

expert video

Expert Insights: Importance of Lung Function Assessment in Pediatric Asthma Patients

2 min

Pulmonology

Dr. Michael Blaiss describes the importance of lung function assessment in pediatric asthma management.

Importance of Lung Function Assessment in Pediatric <b>Asthma</b> Patients

videoanimation

Importance of Lung Function Assessment in Pediatric Asthma Patients

3 min

Pulmonology

Review the burden associated with lung function decline in pediatric patients with severe asthma and the value of clinical lung function assessments.

videoanimation

Type 2 Inflammation and Airway Remodeling Drive Lung Function Decline

4 min

Pulmonology

Explore the impact of type 2 inflammation and airway remodeling on lung function decline in asthma.

expert video

How Can FeNO Measurement Improve Severe Asthma Management?

7 min

Pulmonology

Join Dr. Miguel Lanz as he explains the clinical utility of FeNO as a biomarker of severe asthma.

Concerns Surrounding OCS Side Effects in Patients With Severe <b>Asthma</b>

expert video

Concerns Surrounding OCS Side Effects in Patients With Severe Asthma

2 min

Pulmonology

Review the possible consequences of regular oral corticosteroid use in asthma.

Importance of Lung Function Assessment in Adult <b>Asthma</b> Patients

videoanimation

Importance of Lung Function Assessment in Adult Asthma Patients

3 min

Pulmonology

Review the burden associated with lung function decline in adult patients with severe asthma, and the value of clinical lung function assessments.

ERS 2024 | Pathophysiologic Mechanisms of Airway Remodeling in Severe <b>Asthma</b>

expert video

ERS 2024 | Pathophysiologic Mechanisms of Airway Remodeling in Severe Asthma

14 min

Pulmonology

Professor Celeste Porsbjerg presents the pathophysiology and disease processes involved in airway remodeling in severe asthma.

OCS Use in Severe <b>Asthma</b> Is Often Associated With Adverse Effects

Infographic

OCS Use in Severe Asthma Is Often Associated With Adverse Effects

5 min

Pulmonology

Uncover the risks associated with OCS in patients with severe asthma.

expert video

ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

78 min

Pulmonology

Professors Celeste Porsbjerg and Klaus Rabe and Dr Mario Castro discuss the pathophysiology of airway remodeling and its impact on patients with severe asthma.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region